Literature DB >> 1462876

The bradykinin antagonist Hoe 140 inhibits carrageenan- and thermically induced paw oedema in rats.

K J Wirth1, H G Alpermann, R Satoh, M Inazu.   

Abstract

The new and highly potent B2 bradykinin (BK) antagonist Hoe 140 was tested for its ability to inhibit oedema of rat paws induced by scalding and carrageenan. The data show that Hoe 140 inhibits scalding and carrageenan oedema for more than four and six hours, respectively. Based on its potency against actions of endogenously generated kinins Hoe 140 is appropriate to investigate the role of kinins in human inflammatory diseases.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1462876

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN： 0379-0363


  5 in total

1.  Pro-inflammatory properties of the kallikrein-kinin system: potential for new drug therapy.

Authors:  J N Sharma; A P Yusof
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

2.  Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice.

Authors:  A Rawlingson; N P Gerard; S D Brain
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Alcohol potentiates postburn remote organ damage through shifts in fluid compartments mediated by bradykinin.

Authors:  Michael M Chen; Eileen B O'Halloran; Jill A Ippolito; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

4.  Burn model for in vivo investigations of microcirculatory changes.

Authors:  Ole Goertz; Julian Vogelpohl; Birger Jettkant; Adrien Daigeler; Hans Ulrich Steinau; Lars Steinstraesser; Stefan Langer
Journal:  Eplasty       Date:  2009-04-03

5.  Inhibition of plasma kallikrein by a highly specific active site blocking antibody.

Authors:  Jon A Kenniston; Ryan R Faucette; Diana Martik; Stephen R Comeau; Allison P Lindberg; Kris J Kopacz; Gregory P Conley; Jie Chen; Malini Viswanathan; Niksa Kastrapeli; Janja Cosic; Shauna Mason; Mike DiLeo; Jan Abendroth; Petr Kuzmic; Robert C Ladner; Thomas E Edwards; Christopher TenHoor; Burt A Adelman; Andrew E Nixon; Daniel J Sexton
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.